A major breakthrough in cancer research is occurring with the use of nanobodies to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently disabled in several forms of cancer, leading https://onlybookmarkings.com/story21836535/mini-antibodies-restore-tumor-suppressor-p53-new-new-hope-for-malignant-management